Funnelens

Owlet

Facebook · Instagram · Audience Network · Video

Active
Days running
52 days
Funnel score
45/100
Page speed
38/100

The ad

Owlet ad creative

RSV season is stressful, but getting BabySat isn't. Secure a quick prescription online and keep a close eye on your baby's health.

FDA-Cleared BabySat Monitoring System

Learn more
Angle: Stress relief through convenience and health monitoringHook: Problem-solution (acknowledging pain point then offering relief)Format: Video

The funnel behind it

Owlet landing page

Offer: Introducing the BabySat® monitoring system, a prescription and is intended for babies aged 1-18 months and between 6-30 lbs who could benefit from additional monitoring at home, under the supervision of a physician on ongoing medical needs.

45/ 100

Funnel score

8-point CRO breakdown

How well the landing page behind the ad is built to convert, scored across 8 factors: offer, copy, speed, trust, mobile, message-match, CTA, and social proof.

This page does well establishing medical credibility through FDA-clearance messaging, detailed product features (medical-grade accuracy, live vital signs tracking), and multiple CTAs targeting healthcare providers. However, it suffers from poor page speed (38/100), weak social proof (no reviews, testimonials, or usage statistics visible), and messaging misalignment with the ad's consumer-focused "quick prescription online" angle—the page is clearly designed for medical professionals, not parents seeking quick access. The primary CTA "RX Order Form" is clinical and uninviting for consumers, and the offer clarity is muddled by regulatory language that obscures the actual value proposition.

What this funnel does right. Steal these.

  • Headline7/10

Where it's weak

  • Social proof1/10
  • Message match3/10
  • Call to action4/10
  • Page speed4/10
  • Offer clarity5/10

Full breakdown

Call to action

4/10

Primary CTA 'RX Order Form' is clinical and passive; secondary CTAs ('Learn More', 'Download here', 'Contact Us') are scattered and lack urgency.

What works
  • Primary CTA button is visually prominent (dark teal, full-width above fold)
  • Multiple CTAs throughout page offer different entry points
  • Clear visual hierarchy with button styling
What hurts
  • 'RX Order Form' is clinical jargon that alienates consumers; doesn't match ad's 'quick prescription online' promise
  • No urgency language (e.g., 'Get Started', 'Secure Your Prescription', 'Order Now')
  • Secondary CTAs like 'Learn More' and 'Download here' are weak and don't drive conversion

Page speed

4/10

PAGESPEED_SCORE of 38 converts to approximately 3.8/10; this is critically slow and will cause abandonment, especially on mobile.

What hurts
  • Page speed score of 38/100 is in the poor range
  • Multiple high-resolution images (product mockup, lifestyle photo, clinical documents) likely unoptimized
  • Likely JavaScript-heavy expandable sections and form interactions

Trust signals

6/10

FDA-clearance and clinical language build some trust, but lack of customer proof, privacy details, and company transparency limit credibility.

What works
  • FDA-Cleared status prominently displayed and repeated throughout
  • Clinical study PDFs available for download (whitepapers section)
  • Specific medical indications listed (cardiac/respiratory conditions)
What hurts
  • No customer reviews or testimonials to validate claims
  • No company background, team credentials, or 'About Us' visible
  • Privacy policy link present but buried at bottom; no trust badges or certifications visible

Mobile experience

6/10

Layout is responsive and readable on mobile, but long scrolling and stacked sections create friction; form fields visible at bottom are small.

What works
  • Text is readable and properly sized for mobile
  • Buttons are large enough to tap (primary CTA is full-width)
  • Images scale appropriately and don't overflow
What hurts
  • Excessive vertical scrolling required to reach CTAs (multiple 'Learn More' sections before conversion)
  • Expandable FAQ sections require tapping to reveal content, adding friction
  • Email and date input fields at bottom are small and cramped

Headline

7/10

Headline is clear and credible but generic; it names the product and FDA status but doesn't communicate the emotional benefit or urgency.

What works
  • FDA-Cleared status builds trust immediately
  • Product name is specific (BabySat®)
  • Monitoring System clearly indicates function
What hurts
  • No emotional hook or benefit statement (e.g., 'peace of mind', 'early detection')
  • Doesn't address the ad's angle about RSV season stress or quick access
  • Generic product-name format lacks differentiation

Social proof

1/10

No customer reviews, testimonials, usage statistics, clinical trial data, or endorsements visible anywhere on the page.

What hurts
  • Zero customer testimonials or reviews despite multiple page sections
  • No usage statistics (e.g., 'trusted by X hospitals' or 'X babies monitored')
  • Clinical studies mentioned as downloadable PDFs but no summary stats or quotes on page

Message match

3/10

Ad promises 'quick prescription online' and targets stressed parents during RSV season; page is designed for medical professionals and emphasizes clinical features, not consumer convenience.

What works
  • Both ad and page mention FDA-cleared status
  • Both reference prescription requirement
  • Product name (BabySat) matches between ad and page
What hurts
  • Ad targets parents ('RSV season is stressful'); page targets providers ('I am a medical provider, how can my practice get started')
  • Ad emphasizes speed ('quick prescription'); page emphasizes clinical workflow and integration
  • Ad's consumer angle (health monitoring) vs. page's provider angle (EMR integration, clinician workflows)

Offer clarity

5/10

The offer is buried in regulatory language and unclear whether this is for consumers or providers; the actual value (monitoring system for at-risk infants) is stated but the process and pricing are absent.

What works
  • FDA-cleared status prominently displayed in headline
  • Target age range (1-18 months, 6-30 lbs) clearly specified
  • Key features listed (medical-grade accuracy, live vital signs, customizable alarms)
What hurts
  • Prescription requirement mentioned but process unclear—does consumer order directly or request from doctor?
  • No pricing, shipping time, or what's included in the system
  • Regulatory language ('intended for babies...under supervision of a physician') obscures consumer benefit

More ads from Owlet

View all →

Your own page

You just read somebody else's funnel. What does yours score?

The score above came from the real landing page behind this ad, graded on 8 CRO factors. Run your own page through the same rubric, free, and see what each factor found and where you give up the most ground.

Free, no signup, no card. The same 8 factor score every page here was graded on.

Keep exploring

Data from the public Meta Ad Library. Funnelens is not affiliated with or endorsed by Meta. See data sources.